Omnicell to Highlight New Interoperability Alliance with Cerner at Medication Safety Conference in Abu Dhabi, UAE

Informations

• Publié par: OMNICELL
• Nombre de lectures: 20
• Langue: English

Extrait

Omnicell to Highlight New Interoperability Alliance with Cerner at Medication Safety Conference in Abu Dhabi, UAE

PR Newswire MOUNTAIN VIEW, California, Nov. 15, 2012

- The Company Will Also Sponsor a Symposium on the Benefits of Medication Management during the Conference

MOUNTAIN VIEW, California,Nov. 15, 2012/PRNewswire/ --Omnicell, Inc. (NASDAQ:OMCL), a leading global provider of medication and supply management solutions and analytics software for healthcare facilities, will sponsor a symposium entitled, "Will Medication Management Improve a Patient's Health?" concurrent with its presence at the Medication Safety Conference in Abu Dhabi, UAE, onNovember 15-17.

Omnicell, Inc As part of the conference, the invitation-only symposium onFriday, November 16, will cover medication management in both hospital and community settings and how the use of electronic information systems can impact patient outcomes. The featured speakers are:

Amir Emamifar, Pharm D, MBA, Associate Administrator, Pharmaceutical Services atEmory University Hospitals and Clinics in Atlanta, Georgia, USA. Dr. Emamifar will speak about how the capabilities of medication technologies and hospital information systems affect patient outcomes in an academic teaching hospital. David Thomson, Pharmacist, Scotland, will highlight the capabilities of medication adherence solutions and their effect on patient outcomes in a community setting. Deirdre Stewart, RGN, RPN, PGDip HCI, Chief Nursing Officer, Cerner Middle East, will discuss how moving from paper to electronic systems has impacted patient outcomes and how evolving technology allows for earlier intervention when compliance or medication effectiveness is impacted.

Attendees will be able to meet Omnicell experts during the conference to discuss the recently announced alignment between Cerner and Omnicell. The agreement between the two companies is focused on interoperability between Cerner® and Omnicell® systems using theCernerCareAware®connectivity architecture. This relationship was formed to decrease implementation costs, time, and maintenance for shared clients, while providing new clinical workflows to enhance efficiency and patient safety.

"We are pleased to have the opportunity to discuss our new agreement with Cerner and the positive impacts we believe this will bring to our customers throughout the Middle East," said Marga Ortigas-Wedekind, Omnicell executive vice president, global marketing and product development.

Omnicell will also display its medication management products during the Medication Safety Conference. Products that will be available for demonstration include the award winning OmniRx® automated medication dispensing cabinet, Savvy™ mobile medication workstation and the Anesthesia Workstation™ G4.

These products are all part of Omnicell's G4 platform, which features a single unified medication database-helping to eliminate redundant data entry that can lead to errors. The Savvy mobile medication workstation incorporates the company's exclusive Anywhere RN™ remote medication management software, allowing nurses to queue up medications in quieter areas away from the dispensing cabinet. The Anesthesia Workstation G4 extends the benefits ofautomated medication dispensingand bar code scanning to the operating room. Also featured at the conference will be the integrated Medication Label Printer, a unique Omnicell solution that allows nurses to print patient-specific labels directly from the medication dispensing cabinet to improve safety when medications are not immediately administered to patients.

Omnicell will also feature its medication packaging solutions for both hospital outpatient and non-hospital markets. Through its acquisition of MTS Medication Technologies, an international provider of adherence packaging and automation solutions, Omnicell has added a product line that supports the cost effective and efficient packaging of oral solids. These products offer pharmacies a range of solutions from single dose packaging that improves medication safety and workflow for skilled nursing homes to multi-dose packaging that improves compliance for patients in assisted living or home care who struggle with complex prescription regimens. MTS packaging solutions and automation are currently used by over 6,000 pharmacies worldwide.

"In keeping with the commitment we have made to our customers in theMiddle East, we are delighted to share our latest solutions to deliver innovative safety and efficiency benefits," said Gary Ervin, Omnicell vice president, international. "In addition, we are pleased to offer highly esteemed speakers at our symposium who will present valuable information to the region's pharmacy leaders. We are also excited to introduce our new packaging and medication adherence solutions for outpatient pharm acy and long term care facilities, thereby deepening our

commitment to being a strong partner to healthcare institutions in the Middle East."

About Omnicell

Omnicell, Inc. (NASDAQ:OMCL) is a leading provider of automation and business information solutions enabling hospitals and other healthcare organizations to streamline the medication administration process and m anage costly medical supplies for increased operational efficiency and enhanced patient safety. Through seam less integration with a customer's existing IT infrastructure, Omnicell solutions empower healthcare facilities to achieve comprehensive automation of medication and supply m anagement from the arrival at the loading dock to the patient's bedside. Omnicell also provides healthcare facilities with business analytics software designed to improve medication diversion detection and regulatory compliance.

Since 1992, more than 2,600 hospital customers worldwide have utilized Omnicell's medication automation, supply chain, and analytics solutions to enable them to increase patient safety, improve efficiency and address changing healthcare regulations while providing effective control of costs, charge capture for payer reimbursem ent and inventory management of medications and supplies.

MTS Medication Technologies, a wholly owned Omnicell subsidiary, is a leader in medication adherence packaging systems designed to improve medication dispensing and administration. MTS enables approximately 6,000 institutional and retail pharmacies worldwide to maintain high accuracy and quality standards while optimizing productivity and controlling costs. The MTS product line includes more than 20 packaging machines and 50 types of consumable products.

For more information about Omnicell, please visitwww.omnicell.com. Visitwww.mts-mt.comfor more information about MTS.

OMCL - G